Can Very Low Dose Rivaroxaban in Addition to Dual Antiplatelet Therapy (DAPT) Improve Thrombotic Status in Acute Coronray Syndrome (ACS) ACS
Clinical trial NCT03775746 · UNKNOWN
Trial details
- NCT number
- NCT03775746
- Sponsor
- East and North Hertfordshire NHS Trust
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-08
- Primary completion
- 2021-12-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.